2 results
Approved WMOCompleted
To prove superiority of Fermathron plus in the treatment of patients with mild knee OA compared to placebo
Approved WMOCompleted
Efficacy ObjectivesThe primary efficacy objective of study GO28141 is as follows:* To evaluate the efficacy of vemurafenib in combination with GDC-0973, compared with vemurafenib and placebo, in previously untreated BRAFV600 mutation-positive…